Skip to main content

Table 2 Distribution of B cell non Hodgkin lymphoma by diagnosis and immunophenotype

From: Immunohistochemical and other prognostic factors in B cell non Hodgkin lymphoma patients, Kampala, Uganda

Diagnosis

    

Marker

Burkitt

lymphoma

(%positive)

Diffuse large B cell lymphoma (% positive)

Precursor B lymphoblastic lymphoma

Mantle cell lymphoma

CD10

74/79(93.7)

3/18 (16.7)

1/1

0/4

CD20

95/95(100)

19/19(100)

1/1

4/4

BCL6

46/69(66.7)

2/19(10.5)

0/1

1/4

CD79a

48/68(70.6)

6/16(37.5)

1/1

2/4

CD38

35/68(51.5)

3/16(18.8)

0/1

0/4

MUM-1/IRF4

1/77(1.3)

4/18(22.2)

0/1

0/4

EBER

79/86(91.9)

6/17(35.3)

1/1

0/4

Tdt

0/95(0)

0/19(0)

1/1

0/4

BCL2

6/79(7.6)

7/19(36.8)

1/1

4/4

CD3

0/86(0)

0/19(0)

0/1

0/3

CD138

43/95(45.3)

10/15(66.7)

0/1

4/4

CD30

35/95(36.8)

2/17(11.8)

0/1

0/4